Journal
/
/
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
DOI:

12:42 min

January 07, 2019

,

Chapters

  • 00:04Title
  • 00:47Generation of Recombinant Virus Particles
  • 02:47Collection and Propagation of Virus Particles
  • 05:11Viral Titer Evaluation
  • 06:59Determining Replicative and Cytotoxic Capacities of Viral Vectors Encoding Immunomodulators
  • 08:03Assessment of Immunological Functionality of Isolated Virus-encoded Immunomodulators from Infected Cells
  • 10:00Results: Evaluation of Tumor-targeted Immunomodulation by Paramyxoviruses
  • 11:37Conclusion

Summary

Automatic Translation

This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical translation.

Related Videos

Read Article